TherapeuticsMD Inc expected to post a loss of $1.11 a share - Earnings Preview

TherapeuticsMD

07/04/2023 13:44

* TherapeuticsMD Inc  TXMD.OQ   TXMD.O  is expected to show
a rise
in quarterly revenue when it reports  results on April 10
(estimated). 
    * The Boca Raton Florida-based  company is expected to
report  a
27.4% increase in revenue to $23.8 million from $18.68 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for TherapeuticsMD Inc
is for
a loss of $1.11 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
TherapeuticsMD
Inc is $5​, above​ its last closing price of $3.56. ​​​

This summary was machine generated April 7 at 12:44 GMT.  All
figures in US dollars  unless otherwise stated